Circulating metabolites of sEH were associated with cerebral small vessel disease and with poorer performance in associated cognitive domains [43, 44], offering one possible explanation for the preservation of psychomotor processing speed seen here. This evidence concerns the gene EPHX2 and cerebral small vessel disease.